Genetic deletion of P-selectin prevents fibrosis development by inhibiting the neutrophil megakaryocyte emperipolesis in the Gata1low mouse model for myelofibrosis
European Journal of Histochemistry · 2025
DOI: 10.4081/ejh.2025.4427 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Histochemistry, 2025. Verfasst von Francesca Arciprete und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Microscopic and Ultrastructural Anatomy, Campus Bio Medico University of Rome. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Megakaryocytes, P-Selectin, Neutrophils. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Myelofibrosis (MF) is a rare chronic hematological disorder, within the family of myeloproliferative neoplasms. The MF patients present clinical abnormalities such as anemia, and thrombosis, as well as alterations in the bone marrow (BM) microenvironment, an increased number of megakaryocytes (MKs), most of which are found in emperipolesis with neutrophils. In MF, the MKs emperipolesis is induced by an altered MK secretome, containing increased levels of pro-inflammatory cytokines, proteins, and growth factors such as interleukin-8 (IL-8) and P-selectin (P-sel). These, allow the altered cell-to-cell interactions and cause the transforming growth factor-β (TGF-β) to be released into the BM microenvironment. This fibrogenic cytokine contributes to BM fibrosis and disease progression. Emperipolesis has already been identified as a pathobiological event that contributes to MF and it is widely recognized in the most advanced stages of the disease. In this study, we evaluated the role of P-sel in BM alterations associated with emperipolesis in the Gata1low mouse model of MF. Our data show that emperipolesis is driven by P-sel. Genetic ablation of P-sel rescued the BM microenvironment, by decreasing fibrosis, suggesting that pharmacological targeting of P-sel could contribute to reduce the BM dysfunction and disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Microscopic and Ultrastructural Anatomy, Campus Bio Medico University of Rome.
- BENA, Italian National Institute of Health, Rome.
- Department of Oncology and Molecular Medicine, Italian National Institute of Health, Rome.
- National Centre for Rare Diseases, Italian National Institute of Health, Rome.
- Department of Medicine and Surgery (DiMeC), Anatomy Unit, University of Parma.
- Fondazione Policlinico Campus Bio-Medico University of Rome.
ORCID-Profile: Francesca Arciprete
Zitieren
APA
Arciprete, F., Velardi, V., Di Virgilio, A., Verachi, P., Carta, C., Pozzi, G., Roberti, V., Vivacqua, G., Rana, R., & Zingariello, M. (2025). Genetic deletion of P-selectin prevents fibrosis development by inhibiting the neutrophil megakaryocyte emperipolesis in the Gata1low mouse model for myelofibrosis. European Journal of Histochemistry. https://doi.org/10.4081/ejh.2025.4427
Vancouver
Arciprete F, Velardi V, Di Virgilio A, Verachi P, Carta C, Pozzi G, et al. Genetic deletion of P-selectin prevents fibrosis development by inhibiting the neutrophil megakaryocyte emperipolesis in the Gata1low mouse model for myelofibrosis. European Journal of Histochemistry. 2025. doi:10.4081/ejh.2025.4427
BibTeX
@article{Arciprete2025,
author = {Arciprete, Francesca and Velardi, Viola and Di Virgilio, Antonio and Verachi, Paola and Carta, Claudio and Pozzi, Giulia and Roberti, Vincenzo and Vivacqua, Giorgio and Rana, Rosalba and Zingariello, Maria},
title = {Genetic deletion of P-selectin prevents fibrosis development by inhibiting the neutrophil megakaryocyte emperipolesis in the Gata1low mouse model for myelofibrosis},
journal = {European Journal of Histochemistry},
year = {2025},
doi = {10.4081/ejh.2025.4427}
}
EUVIMED